alzheimers

A new study performed by the University College London discovered an anti-viral gene that influences the risk of both Alzheimer's disease and severe COVID-19. The findings might pave the way for novel therapeutic targets or assessing disease progression in either disease, as well as imply that therapies produced could be utilised for both diseases. The results may potentially have implications for other viral diseases and dementias.